The global central venous catheters (CVCs) market is expected to grow at a 5.3% CAGR from US$ 1.3 billion in 2022 to US$ 1.6 billion by 2026. The global market for medical devices used to insert catheters into large veins for various medical purposes is referred to as the Central Venous Catheters (CVCs) Market. These catheters, which are typically made of silicone or polyurethane, can be placed in the internal jugular, subclavian, or femoral veins. CVCs are commonly used in critical care settings for patients who require long-term intravenous medications, nutrition, or blood products. Patients who require hemodialysis, apheresis, or plasmapheresis may also benefit from them. In addition, CVCs are used to monitor central venous pressure (CVP).

The global CVCs market is expected to expand significantly over the next few years, owing to rising chronic disease prevalence, rising demand for advanced medical devices, and rising healthcare expenditure.

Download Free Sample Copy of this Report - https://www.factmr.com/connectus/sample?flag=S&rep_id=7645

Key Takeaways from Central Venous Catheters Market Study

• The global CVCs market is currently valued at US$ 1.3 billion.
• Market in Germany projected to increase at CAGR of 5% through 2026.
• Market in Japan anticipated to rise at 4.5% CAGR over forecast period.
• Sales of triple-lumen central venous catheters expected to increase at CAGR of 5.5% from 2022 to 2026.

Key Segments in Central Venous Catheters Industry Research

• By Design :
  • Multi-Lumen
  • Triple-Lumen
  • Double-Lumen
  • Single-Lumen
• By Property :
  • Non-antimicrobial Coated
  • Antimicrobial Coated
• By Application :
  • Jugular Vein
  • Femoral Vein
  • Subclavian Vein
• By End User :
  • Hospitals
  • Ambulatory Surgical Centers
  • Others

Region-Wise Analysis

The central venous catheters (CVCs) market is a global market that can be segmented into various regions including North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. North America holds the largest share of the market due to the high adoption of advanced technologies, increasing prevalence of chronic diseases, and rising geriatric population. Europe is also a significant market due to the presence of established healthcare infrastructure and high healthcare expenditure. The Asia-Pacific region is expected to grow rapidly due to increasing healthcare expenditure, rising awareness about healthcare, and growing geriatric population. The market in Latin America and Middle East & Africa is expected to grow moderately due to improving healthcare infrastructure and rising investments in the healthcare sector

Get Customization on this Report for Specific Research Solutions - https://www.factmr.com/connectus/sample?flag=RC&rep_id=7645

Winning Strategy

To lower bloodstream infections, market companies are focusing on launching antimicrobial-coated catheters and stepping up their R&D efforts. To minimise risks and ensure patient safety, central venous catheter manufacturers are putting more focus on investments in product quality and design.

In the upcoming years, industry players believe that regulatory authority suggestions regarding the categorization of central venous catheters, which are now being sought for, will significantly fuel market expansion.

For instance,

• In 2020, for detection, monitoring, and analysis of the radiofrequency and energy delivery during cardiac ablation treatments, Boston Scientific Corporation introduced the DIRECTSENSE technology tool, which is implanted at the tip of a catheter.

Key players in the Central Venous Catheters Market

• Amecath
• Medtronic Plc
• Smiths Medical, Inc.
• Teleflex Incorporated
• Vygon Ltd.
• ZOLL Medical Corporation
• AngioDynamics Inc.
• B. Braun Melsungen AG
• Bactiguard AB
• Becton, Dickinson and Company

Original Source of the original story >> Global Central Venous Catheters (CVCs) Market to Expand Due to Rising Prevalence of Chronic Diseases